Term
Amiodarone (Cordarone)
Class |
|
Definition
Class:
Class III antidysrhythmic |
|
|
Term
Amiodarone (Cordarone)
Actions |
|
Definition
Actions
1) Noncompetetive alpha/ beta adrenergic blocking properties
2) Prolongs duration of action potential and effective refractory period which slows conduction |
|
|
Term
Amiodarone (Cordarone)
Indications |
|
Definition
Indications
1) VF or VT cardiac arrest
2) Control of hemodynamically stable VT, polymorphic VT and wide-complex tachycardia of uncertain origin
3) Refractory PSVT's, atrial tachycardia, and pharmocological cardioversion of AF
4) Control rapid ventricular rate due to accessory pathway conduction in preexcited atrial arrythmias |
|
|
Term
Amiodarone (Cordarone)
Dosage/ Routes |
|
Definition
Dosage/ Routes
VF/VT cardiac arrest: 300 mg IV followed by 10 cc NS flush (2005 ACLS Guideline book mentions that a supplementary dose of 150 mg IV may be given for recurrent or refractory VT/VF)
For pt not in cardiac arrest: 150 mg IV over 10 minutes, followed by infusion of 1 mg/ min over 6 hrs |
|
|
Term
Amiodarone (Cordarone)
Standard preps |
|
Definition
Standard Prep
150 mg in 3 cc ampule |
|
|
Term
Amiodarone (Cordarone)
Contraindications |
|
Definition
Amio Contraindications
1) Hypersensitivity
2) Cardiogenic Shock
3) Hypotension
4) Pulmonary congestion |
|
|
Term
Amiodarone (Cordarone)
Side Effects |
|
Definition
Amio Side effects
1) Hypotension
2) Bradycardia
3) Hepatotoxicity
4) CHF, pulmonary fibrosis
5) Misc.: flushing, abnormal salivation |
|
|
Term
Amiodarone (Cordarone)
Precautions |
|
Definition
Amio Precautions
Do not shake vial because it will foam
Monitor infusion rate carefully
Monitor VS, EKG, lung sounds, and mental status |
|
|
Term
|
Definition
Atropine Sulfate Class
Parasympatholytic
Anticholinergic (vagolytic)
|
|
|
Term
|
Definition
Atropine Actions
Blocks effects of parasympathetic innervation to the heart which enhances both sinus node automaticity and AV conduction
Relaxes smooth muscle in bronchial tree = bronchodilation
• Inhibits glandular secretion in respiratory tract
• Inhibits secretions from sweat and salivary glands
• Decreases gastrointestinal motility |
|
|
Term
Atropine Sulfate
Indications |
|
Definition
Atropine Indications
Symptomatic bradyarrhythmias
• Symptomatic conduction defects, ie. Stokes-Adams syndrome
•
CPA (asystole, PEA algorithm)
• Organophosphate (cholinergic) poisoning
• Status asthmaticus (aerosol nebulizer route)
|
|
|
Term
Atropine Sulfate
Dosage/ Route |
|
Definition
Atropine Dosage
Hawaii SO: Symptomatic Brady .5mg w/ total dose of 3 mg
Organophosphate poisoining: Autoinjector 2 mg x 3 total doses
Respiratory Difficulty: 1.0 mg via Nebulizer w/ beta-2 agonist for adults usual routes IV, ET. |
|
|
Term
Atropine Sulfate
Standard Prep |
|
Definition
Atropine
Standard prep
1 mg/ 10cc preloaded syringe |
|
|
Term
Atropine Sulfate
Peds Dose |
|
Definition
Atropine Peds dose
Directed by base station |
|
|
Term
Atropine Sulfate
Side effects |
|
Definition
Atropine: Side effects
Acute psychosis, vasodilation, dehydration, elevated surface temp., mydriasis. Mad as a hatter, red as a beet, dry as a bone, hot as a hare, blind as a bat.
|
|
|
Term
Atropine Sulfate
Precautions |
|
Definition
Atropine Precautions
MONITOR VS, EKG, & mental status
•
May increase myocardial O2 demand in MI patients and aggravate chest pain •
Too low a dose may cause paradoxical bradycardia
•
Exacerbation of glaucoma
Can cause acute urinary retention in males with enlarged prostate
|
|
|
Term
Atropine Sulfate
Additional Notes and Precautions
|
|
Definition
Atropine additional notes and precautions
ACLS: Atropine has been reported to be harmful in some patients with AV block at the HIS-Purkinje level (type II AV block and third-degree AV block with a new wide-QRS complex).
Atropine may be used in these situations, but watch closely for paradoxical slowing.
|
|
|
Term
Dopamine (INTROPIN®)
Class |
|
Definition
Dopamine (Intropin)
Class
Catecholamine
Sympathomimetic |
|
|
Term
Dopamine (INTROPIN®)
Actions |
|
Definition
Dopamine (Intropin)
Actions
Dose dependent sympathomimetic
At lower drip rates of 1-2 ug/kg/min, stimulate dopaminergic receptors to produce cerebral, renal, and mesenteric vasodilation
At drip rates of 2-10 ug/kg/min, B1 effects predominate
(predominantly inotropic effect) with alpha effect beginning (vasoconstriction)
At drip rates 10 -20ug/kg/min, alpha effects predominate with renal, mesenteric, and peripheral arterial, and venous vasoconstriction with marked increae in SVR (systemic vascular resistance)
At drip rates > 20ug/kg/min alpha effects similar to norepinephrine predominate with marked peripheral vasoconstriction and tachycardia
|
|
|
Term
Dopamine (INTROPIN®)
Indications |
|
Definition
Dopamine (Intropin)
Indications
Cardiogenic shock
Other types of shock after adequate fluid resuscitation
Symptomatic bradycardia unresponsive to Atropine or external pacemaker
|
|
|
Term
Dopamine (INTROPIN®)
Dosage/ Route |
|
Definition
Dopamine (Intropin)
Dosage Route
Titrate 5- 20 mcg/kg/min |
|
|
Term
Dopamine (INTROPIN®)
Standard Prep |
|
Definition
Dopamine (Intropin)
Standard Prep
400mg/ 250cc (premixed) |
|
|
Term
Dopamine (INTROPIN®)
Contraindications |
|
Definition
Dopamine (Intropin)
Contraindications
Hypovolemia BEFORE fluid resuscitation
• Pts. taking monamine oxidase inhibitors
Pheochromocytoma (can precipitate hypertensive crisis)
• Uncorrected tachyarrhythmias
|
|
|
Term
Dopamine (INTROPIN®)
Side Effects |
|
Definition
Dopamine (Intropin)
Side Effects
Tachyarrhythmias
Hypertension precipitate myocardial ischemia
Tissue necrosis with extravasation (infiltration) |
|
|
Term
Dopamine (INTROPIN®)
Precautions |
|
Definition
Dopamine (Intropin)
Precautions
Monitor VS and EKG
Stop infusion if diastolic pressure rises > 90 mm Hg
• Incompatible with NaHCO3 since alkaline environment may inactivate dopamine
Avoid extravasation which will cause tissue necrosis and tissue sloughing. Inform ER RN or MD since local injection of Regitine will be required.
|
|
|